Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

FDA Approval of Zenocutuzumab for Advanced NRG1 Fusion-Positive NSCL…

Memorial Sloan Kettering Cancer Center

A. Schram

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Imaging in Pancreatic Cancer: Radiologist's Insights

14th International Gastrointestinal Cancers Conference (IGICC2024)

V. Đurović Sarajlić

ASCO® GI 2025 Insights: Impact of UGT1A1*28 Polymorphism on Treatmen…

Insights from 2025 ASCO® GI Annual Meeting

M. Abdelrahim

ASCO® GI 2025 Insights: Real-World Evidence of Nanoliposomal Irinote…

Insights from 2025 ASCO® GI Annual Meeting

T. Shirakawa

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ASCO® GI 2025 Insights: Unlocking the Potential of ADCs in Pancreati…

Insights from 2025 ASCO® GI Annual Meeting

L. Zheng

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: …

Yale Cancer Center

M. Cecchini

Overcoming Clinical Barriers: Integrating Liposomal Irinotecan Into …

Massachusetts General Hospital Cancer Center

P. Pathak

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

ASCO® GI 2025 Insights: Phase 1b Study of Gemcitabine & Nab-Paclitax…

Insights from 2025 ASCO® GI Annual Meeting

S. Pant

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

Clinical Takeaways in From Recent Key Trials in Pancreatic Cancer

Hani Babiker